vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Postal Realty Trust, Inc. (PSTL). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $26.0M, roughly 1.2× Postal Realty Trust, Inc.). Postal Realty Trust, Inc. runs the higher net margin — 17.9% vs -32.1%, a 50.0% gap on every dollar of revenue. On growth, Postal Realty Trust, Inc. posted the faster year-over-year revenue change (21.7% vs -4.5%). Postal Realty Trust, Inc. produced more free cash flow last quarter ($37.6M vs $25.0K). Over the past eight quarters, Postal Realty Trust, Inc.'s revenue compounded faster (22.6% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Postal Realty Trust, Inc. is a specialized real estate investment trust that acquires, owns, and manages properties primarily leased to the United States Postal Service. Its portfolio includes last-mile postal facilities, sorting centers, and retail post office locations across the U.S., supporting critical mail and package delivery infrastructure.
LFCR vs PSTL — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $26.0M |
| Net Profit | $-10.0M | $4.6M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 39.2% |
| Net Margin | -32.1% | 17.9% |
| Revenue YoY | -4.5% | 21.7% |
| Net Profit YoY | -52.0% | 3.1% |
| EPS (diluted) | $-0.29 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $26.0M | ||
| Q3 25 | $31.1M | $24.3M | ||
| Q2 25 | — | $23.4M | ||
| Q1 25 | $35.2M | $22.1M | ||
| Q4 24 | $32.6M | $21.4M | ||
| Q3 24 | $24.7M | $19.7M | ||
| Q2 24 | — | $18.1M | ||
| Q1 24 | $35.7M | $17.3M |
| Q4 25 | — | $4.6M | ||
| Q3 25 | $-10.0M | $3.8M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | $-14.8M | $2.1M | ||
| Q4 24 | $-6.6M | $4.5M | ||
| Q3 24 | $-16.2M | $1.1M | ||
| Q2 24 | — | $817.0K | ||
| Q1 24 | $15.6M | $206.0K |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 39.2% | ||
| Q3 25 | -9.9% | 37.6% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | -25.7% | 28.4% | ||
| Q4 24 | -6.0% | 43.2% | ||
| Q3 24 | -46.9% | 24.3% | ||
| Q2 24 | — | 22.8% | ||
| Q1 24 | -2.5% | 17.6% |
| Q4 25 | — | 17.9% | ||
| Q3 25 | -32.1% | 15.7% | ||
| Q2 25 | — | 15.5% | ||
| Q1 25 | -42.0% | 9.4% | ||
| Q4 24 | -20.2% | 21.1% | ||
| Q3 24 | -65.7% | 5.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | 43.8% | 1.2% |
| Q4 25 | — | $0.16 | ||
| Q3 25 | $-0.29 | $0.13 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | $-0.47 | $0.06 | ||
| Q4 24 | $-0.25 | $0.17 | ||
| Q3 24 | $-0.53 | $0.03 | ||
| Q2 24 | — | $0.02 | ||
| Q1 24 | $0.42 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $1.5M |
| Total DebtLower is stronger | $136.0M | $361.1M |
| Stockholders' EquityBook value | $-10.5M | $285.2M |
| Total Assets | $235.2M | $759.1M |
| Debt / EquityLower = less leverage | — | 1.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.5M | ||
| Q3 25 | $18.9M | $1.9M | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | $5.4M | $639.0K | ||
| Q4 24 | $9.5M | $1.8M | ||
| Q3 24 | — | $970.0K | ||
| Q2 24 | — | $1.7M | ||
| Q1 24 | — | $1.9M |
| Q4 25 | — | $361.1M | ||
| Q3 25 | $136.0M | $347.0M | ||
| Q2 25 | — | $328.8M | ||
| Q1 25 | $124.9M | $306.7M | ||
| Q4 24 | $111.3M | $296.7M | ||
| Q3 24 | $106.3M | $277.0M | ||
| Q2 24 | — | $273.7M | ||
| Q1 24 | $97.1M | $247.6M |
| Q4 25 | — | $285.2M | ||
| Q3 25 | $-10.5M | $273.9M | ||
| Q2 25 | — | $250.8M | ||
| Q1 25 | $2.2M | $245.5M | ||
| Q4 24 | $15.4M | $251.3M | ||
| Q3 24 | $-3.9M | $245.6M | ||
| Q2 24 | — | $245.5M | ||
| Q1 24 | $17.7M | $248.1M |
| Q4 25 | — | $759.1M | ||
| Q3 25 | $235.2M | $735.2M | ||
| Q2 25 | — | $689.8M | ||
| Q1 25 | $237.7M | $654.0M | ||
| Q4 24 | $255.4M | $646.8M | ||
| Q3 24 | $246.8M | $615.1M | ||
| Q2 24 | — | $608.2M | ||
| Q1 24 | $246.2M | $584.1M |
| Q4 25 | — | 1.27× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 1.31× | ||
| Q1 25 | 56.05× | 1.25× | ||
| Q4 24 | 7.20× | 1.18× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 1.11× | ||
| Q1 24 | 5.49× | 1.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $44.5M |
| Free Cash FlowOCF − Capex | $25.0K | $37.6M |
| FCF MarginFCF / Revenue | 0.1% | 144.5% |
| Capex IntensityCapex / Revenue | 5.6% | 26.7% |
| Cash ConversionOCF / Net Profit | — | 9.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $65.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $44.5M | ||
| Q3 25 | $1.8M | $10.9M | ||
| Q2 25 | — | $11.4M | ||
| Q1 25 | $1.2M | $10.8M | ||
| Q4 24 | $-6.1M | $33.5M | ||
| Q3 24 | $-613.0K | $8.0M | ||
| Q2 24 | — | $9.9M | ||
| Q1 24 | $-1.4M | $6.4M |
| Q4 25 | — | $37.6M | ||
| Q3 25 | $25.0K | $8.8M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | $-4.3M | $10.2M | ||
| Q4 24 | $-8.6M | $30.7M | ||
| Q3 24 | $-4.0M | $7.4M | ||
| Q2 24 | — | $8.9M | ||
| Q1 24 | $-7.8M | $5.8M |
| Q4 25 | — | 144.5% | ||
| Q3 25 | 0.1% | 36.1% | ||
| Q2 25 | — | 38.8% | ||
| Q1 25 | -12.1% | 45.9% | ||
| Q4 24 | -26.3% | 143.8% | ||
| Q3 24 | -16.3% | 37.6% | ||
| Q2 24 | — | 49.4% | ||
| Q1 24 | -21.8% | 33.6% |
| Q4 25 | — | 26.7% | ||
| Q3 25 | 5.6% | 8.9% | ||
| Q2 25 | — | 10.1% | ||
| Q1 25 | 15.5% | 3.0% | ||
| Q4 24 | 7.5% | 13.0% | ||
| Q3 24 | 13.9% | 3.2% | ||
| Q2 24 | — | 5.4% | ||
| Q1 24 | 17.8% | 3.5% |
| Q4 25 | — | 9.59× | ||
| Q3 25 | — | 2.87× | ||
| Q2 25 | — | 3.16× | ||
| Q1 25 | — | 5.20× | ||
| Q4 24 | — | 7.44× | ||
| Q3 24 | — | 7.48× | ||
| Q2 24 | — | 12.10× | ||
| Q1 24 | -0.09× | 31.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
PSTL
Segment breakdown not available.
